Project Grant R21HD120187
- This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will support a mixed methods research study to investigate the social and behavioral drivers of HIV risk among South African adolescent girls and young women (SA-AGYW). The $244,814 award, effective March 14, 2025 through May 15, 2028, will enable the awardee, the University of...
- This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is intended to study the effects of copper versus levonorgestrel intrauterine devices (IUDs) on the mucosal microbiota and barrier function in young African women living with or at risk of HIV. The $751,405 award, granted on September 22, 2025, will fund a randomized trial to be conducted by Seattle...
- This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $588,566 to the University of Maryland, Baltimore to conduct a cross-disciplinary study on the long-term neurodevelopmental and school readiness impacts of in-utero HIV exposure on children in Sub-Saharan Africa. The research aims to establish a core team of investigators who can...
- The Johns Hopkins University was awarded a $100,170 Project Grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) to characterize the impact of uterine fibroids on the in-utero environment and long-term cardiometabolic health outcomes of offspring. The 2-year grant, beginning July 15, 2025, will leverage the existing resources of the Boston Birth Cohort to test hypotheses related to...
- This federal Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $688,000.00 to Northwestern University to model and characterize the genomic consequences of MED12 mutations in uterine fibroids. The goal is to create disease-relevant human cellular models of uterine fibroids by using CRISPR engineering to introduce specific MED12...
- The National Institute of Child Health and Human Development (NICHD), part of the U.S. Department of Health and Human Services, has awarded a $566,573 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the University of California, San Diego (UCSD). The grant, running from August 1, 2025 to July 31, 2030, will fund a randomized controlled trial to evaluate the impact of point-of-care screening and treatment for Chlamydia trachomatis (CT)...
- This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to Northwestern University provides USD 681,337 to support research on the STAT3 pathway as a therapeutic target for uterine leiomyoma (fibroids). The research aims to: Determine the functional role of the STAT3 pathway in leiomyoma growth in vivo using a patient-derived xenograft mouse model, and Define the cell populations and underlying epigenetic/transcriptomic processes responsible for...
- The National Institute of Child Health and Human Development (NICHD) awarded a $258,556 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to The Johns Hopkins University for a longitudinal study on the association of lifelong antiretroviral treatment (ART) with anti-Mullerian hormone (AMH) levels and fecundability in women living with HIV in Malawi. The study aims to assess the impact of long-term ART on reproductive hormones and fertility...
- This $747,000 Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund research to determine the effects of pre-exposure prophylactic (PrEP) drugs on female genital HIV infection and women's reproductive health. The research will focus on understanding how PrEP impacts the female reproductive tract microenvironment and any potential...
- This Project Grant award, valued at $643,049.00, was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports the development of a physiomimetic model of endometrioma, a type of endometriotic lesion, to study processes driving lesion initiation, ovarian stroma invasion, and persistence in a chronic inflammatory environment. The research aims to uncover...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to determine the prevalence, risk factors, and clinical progression of uterine leiomyomas (fibroids) and examine differences by HIV serostatus among women in Durban, South Africa. The $438,926 grant, awarded on August 19, 2025, will fund a 2-year research project conducted by the University of California, San Diego (UCSD) to: 1) describe the 12-month point prevalence of uterine fibroids by HIV status, 2) examine sociodemographic, reproductive, and sexual health risk factors of fibroids by HIV status, and 3) assess potential differences in fibroid frequency, size, volume, and symptom severity at baseline and 12-month follow-up by HIV status. The research seeks to address the significant impact of both uterine fibroids and HIV infection, particularly among Black women of African descent.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $438.9k | 8/19/25 |